Analyst Reiterates Buy on BrainsWay, Citing Strong Deep TMS Data and SWIFT Coverage Expansion; 12-Month Price Target Maintained at $17
at www.tipranks.com (Thu, 2-Jul 6:35 AM)
BrainsWay Unveils Strong Real-World Deep TMS Data in Comorbid PTSD and Depression
at www.tipranks.com (Mon, 29-Jun 7:57 AM)
